Adirondack Trust Company’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.3K | Hold |
600
| – | – | 0.01% | 338 |
|
|
2025
Q1 | $14.9K | Hold |
600
| – | – | 0.01% | 318 |
|
|
2024
Q4 | $11.3K | Hold |
600
| – | – | ﹤0.01% | 349 |
|
|
2024
Q3 | $9.03K | Hold |
600
| – | – | ﹤0.01% | 371 |
|
|
2024
Q2 | $17.2K | Hold |
600
| – | – | 0.01% | 315 |
|
|
2024
Q1 | $17.5K | Hold |
600
| – | – | 0.01% | 312 |
|
|
2023
Q4 | $17.8K | Hold |
600
| – | – | 0.01% | 312 |
|
|
2023
Q3 | $18.4K | Hold |
600
| – | – | 0.01% | 288 |
|
|
2023
Q2 | $21.8K | Hold |
600
| – | – | 0.01% | 264 |
|
|
2023
Q1 | $24.5K | Hold |
600
| – | – | 0.01% | 252 |
|
|
2022
Q4 | $23.2K | Hold |
600
| – | – | 0.01% | 252 |
|
|
2022
Q3 | $32K | Hold |
600
| – | – | 0.02% | 227 |
|
|
2022
Q2 | $35K | Hold |
600
| – | – | 0.02% | 212 |
|
|
2022
Q1 | $46K | Hold |
600
| – | – | 0.02% | 201 |
|
|
2021
Q4 | $36K | Hold |
600
| – | – | 0.02% | 204 |
|
|
2021
Q3 | $31K | Hold |
600
| – | – | 0.01% | 216 |
|
|
2021
Q2 | $36K | Hold |
600
| – | – | 0.02% | 209 |
|
|
2021
Q1 | $42K | Hold |
600
| – | – | 0.02% | 195 |
|
|
2020
Q4 | $40K | Hold |
600
| – | – | 0.02% | 188 |
|
|
2020
Q3 | $36K | Hold |
600
| – | – | 0.02% | 176 |
|
|
2020
Q2 | $32K | Hold |
600
| – | – | 0.02% | 180 |
|
|
2020
Q1 | $20K | Hold |
600
| – | – | 0.02% | 190 |
|
|
2019
Q4 | $26K | Hold |
600
| – | – | 0.02% | 199 |
|
|
2019
Q3 | $23K | Hold |
600
| – | – | 0.02% | 208 |
|
|
2019
Q2 | $26K | Hold |
600
| – | – | 0.02% | 206 |
|
|
2019
Q1 | $24K | Hold |
600
| – | – | 0.02% | 195 |
|
|
2018
Q4 | $26K | Hold |
600
| – | – | 0.02% | 186 |
|
|
2018
Q3 | $29K | Buy |
+600
| New | +$29K | 0.02% | 189 |
|